UPC vs. INTC
UPC (Universe Pharmaceuticals INC) and INTC (Intel Corporation) are both stocks. UPC operates in Biotechnology (Healthcare), while INTC operates in Semiconductors (Technology). Over the past 5 years, UPC returned -79.99%/yr vs 16.51%/yr for INTC. At a 0.04 correlation, their price movements are largely independent.
Performance
UPC vs. INTC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UPC achieves a -9.71% return, which is significantly lower than INTC's 205.45% return.
UPC
- 1D
- 1.76%
- 1M
- 7.50%
- YTD
- -9.71%
- 6M
- -2.55%
- 1Y
- -24.40%
- 3Y*
- -88.45%
- 5Y*
- -79.99%
- 10Y*
- —
INTC
- 1D
- 4.43%
- 1M
- 17.68%
- YTD
- 205.45%
- 6M
- 157.56%
- 1Y
- 455.50%
- 3Y*
- 54.29%
- 5Y*
- 16.51%
- 10Y*
- 16.05%
UPC vs. INTC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
UPC Universe Pharmaceuticals INC | -9.71% | -84.39% | -97.98% | -76.90% | -11.31% | -65.58% |
INTC Intel Corporation | 205.45% | 84.04% | -59.57% | 94.56% | -46.64% | -17.27% |
Correlation
The correlation between UPC and INTC is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2021 | 0.04 |
Fundamentals
UPC:
$1.94M
INTC:
$572.90B
UPC:
-$22.01
INTC:
-$0.67
UPC:
0.05
INTC:
9.87
UPC:
0.03
INTC:
5.14
UPC:
$40.88M
INTC:
$53.76B
UPC:
$12.37M
INTC:
$19.05B
UPC:
-$10.28M
INTC:
$8.83B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UPC vs. INTC — Risk / Return Rank
UPC
INTC
UPC vs. INTC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Universe Pharmaceuticals INC (UPC) and Intel Corporation (INTC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UPC | INTC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -6.58 | ||
| Sortino ratioReturn per unit of downside risk | -4.56 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.66 | -0.58 |
| Calmar ratioReturn relative to maximum drawdown | -0.32 | 19.00 | -19.32 |
| Martin ratioReturn relative to average drawdown | -0.48 | 45.69 | -46.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UPC | INTC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.19 | 6.39 | -6.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.47 | 0.32 | -0.79 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.48 | 0.36 | -0.84 |
Drawdowns
UPC vs. INTC - Drawdown Comparison
The maximum UPC drawdown since its inception was -99.99%, which is greater than INTC's maximum drawdown of -82.25%. Use the drawdown chart below to compare losses from any high point for UPC and INTC.
Loading charts...
Drawdown Indicators
| UPC | INTC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -82.25% | -17.74% |
Max Drawdown (1Y)Largest decline over 1 year | -76.24% | -24.17% | -52.07% |
Max Drawdown (3Y)Largest decline over 3 years | -99.94% | -63.80% | -36.14% |
Max Drawdown (5Y)Largest decline over 5 years | -99.98% | -65.95% | -34.03% |
Max Drawdown (10Y)Largest decline over 10 years | — | -70.80% | — |
Current DrawdownCurrent decline from peak | -99.98% | -12.92% | -87.06% |
Average DrawdownAverage peak-to-trough decline | -86.25% | -36.68% | -49.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.20% | 10.03% | +41.17% |
Volatility
UPC vs. INTC - Volatility Comparison
Universe Pharmaceuticals INC (UPC) has a higher volatility of 31.76% compared to Intel Corporation (INTC) at 24.93%. This indicates that UPC's price experiences larger fluctuations and is considered to be riskier than INTC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UPC | INTC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.76% | 24.93% | +6.83% |
Volatility (6M)Calculated over the trailing 6-month period | 75.41% | 56.51% | +18.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 131.30% | 71.89% | +59.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 170.13% | 51.58% | +118.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 169.10% | 43.77% | +125.33% |
Dividends
UPC vs. INTC - Dividend Comparison
Neither UPC nor INTC has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INTC Intel Corporation | 0.00% | 0.00% | 1.87% | 1.47% | 5.52% | 2.70% | 2.65% | 2.11% | 2.56% | 2.33% | 2.87% | 2.79% |
UPC Universe Pharmaceuticals INC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UPC vs. INTC - Financials Comparison
This section allows you to compare key financial metrics between Universe Pharmaceuticals INC and Intel Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UPC vs. INTC - Profitability Comparison
UPC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Universe Pharmaceuticals INC reported a gross profit of 3.14M and revenue of 8.71M. Therefore, the gross margin over that period was 36.0%.
INTC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a gross profit of 5.35B and revenue of 13.58B. Therefore, the gross margin over that period was 39.4%.
UPC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Universe Pharmaceuticals INC reported an operating income of -589.16K and revenue of 8.71M, resulting in an operating margin of -6.8%.
INTC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported an operating income of -3.14B and revenue of 13.58B, resulting in an operating margin of -23.1%.
UPC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Universe Pharmaceuticals INC reported a net income of -387.30K and revenue of 8.71M, resulting in a net margin of -4.5%.
INTC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intel Corporation reported a net income of -3.73B and revenue of 13.58B, resulting in a net margin of -27.5%.
Frequently Asked Questions
UPC and INTC have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UPC has higher volatility (31.76%) compared to INTC (24.93%). In terms of maximum drawdown, UPC dropped -99.99% vs INTC's -82.25%.
INTC currently has the higher Sharpe Ratio (6.39 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UPC and INTC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer